CSI Market
Sign In | Register

Neurocrine Biosciences Inc (NBIX) Annual Balance Sheets

Annual · GAAP · USD millions
Access NBIX quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Neurocrine Biosciences Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent713.00
Available-for-sale Securities, Debt Securities, Current MA767.40
Cash & Short-term Investments1,480.00
Accounts receivable686.80
Inventories69.00
Other Current Assets115.80
Prepaid Expense, Current AS170.70
Total Current Assets2,522.70
Equipment/Property/Plant Net89.80
Intangible Assets0.00
Long-term investments1,063.00
Other Assets, Noncurrent2,019.00
Total Assets4,631.50
Liabilities
Accounts Payable and Accrued Liabilities, Current LI674.30
Convertible Debt, Current LO0.00
Other Liabilities, Current69.10
Total Current Liabilities743.40
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent635.00
Total Liabilities1,378.40
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock2,792.20
Retained Earnings / Accumulated Deficit447.70
Other Equity13.10
Common Stockholder's Equity3,253.10
Total Stockholder's Equity3,253.10
Liabilities & Stockholder's Equity4,631.50
4 historic quarters locked

Sign in to unlock the full Neurocrine Biosciences Inc balance sheet history.

Sign In Create Free Account

About Neurocrine Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: nbix-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000914475-26-000007

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License